These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20466542)

  • 1. 1,4-dihydropyrazolo[4,3-d]imidazole phenyl derivatives: a novel type II Raf kinase inhibitors.
    Yu H; Jung Y; Kim H; Lee J; Oh CH; Yoo KH; Sim T; Hah JM
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3805-8. PubMed ID: 20466542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines.
    Lee J; Kim H; Yu H; Chung JY; Oh CH; Yoo KH; Sim T; Hah JM
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1573-7. PubMed ID: 20149658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure based design and syntheses of amino-1H-pyrazole amide derivatives as selective Raf kinase inhibitors in melanoma cells.
    Kim MH; Kim M; Yu H; Kim H; Yoo KH; Sim T; Hah JM
    Bioorg Med Chem; 2011 Mar; 19(6):1915-23. PubMed ID: 21353571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors.
    Zhan W; Li Y; Huang W; Zhao Y; Yao Z; Yu S; Yuan S; Jiang F; Yao S; Li S
    Bioorg Med Chem; 2012 Jul; 20(14):4323-9. PubMed ID: 22721924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses of phenylpyrazolodiazepin-7-ones as conformationally rigid analogs of aminopyrazole amide scaffold and their antiproliferative effects on cancer cells.
    Kim H; Kim M; Lee J; Yu H; Hah JM
    Bioorg Med Chem; 2011 Nov; 19(22):6760-7. PubMed ID: 22014755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies.
    Choi WK; El-Gamal MI; Choi HS; Baek D; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5754-62. PubMed ID: 22014559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.
    Ramurthy S; Subramanian S; Aikawa M; Amiri P; Costales A; Dove J; Fong S; Jansen JM; Levine B; Ma S; McBride CM; Michaelian J; Pick T; Poon DJ; Girish S; Shafer CM; Stuart D; Sung L; Renhowe PA
    J Med Chem; 2008 Nov; 51(22):7049-52. PubMed ID: 18942827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line.
    El-Gamal MI; Choi HS; Cho HG; Hong JH; Yoo KH; Oh CH
    Arch Pharm (Weinheim); 2011 Nov; 344(11):745-54. PubMed ID: 21954060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
    Park JH; El-Gamal MI; Lee YS; Oh CH
    Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoquinoline derivatives with antiproliferative activity against melanoma cell line.
    Nam BS; Kim H; Oh CH; Lee SH; Cho SJ; Sim TB; Hah JM; Kim DJ; Choi JH; Yoo KH
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3517-20. PubMed ID: 19464887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
    El-Gamal MI; Jung MH; Lee WS; Sim T; Yoo KH; Oh CH
    Eur J Med Chem; 2011 Aug; 46(8):3218-26. PubMed ID: 21592628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective pyrazole-based inhibitors of B-Raf kinase.
    Hansen JD; Grina J; Newhouse B; Welch M; Topalov G; Littman N; Callejo M; Gloor S; Martinson M; Laird E; Brandhuber BJ; Vigers G; Morales T; Woessner R; Randolph N; Lyssikatos J; Olivero A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4692-5. PubMed ID: 18676143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of amide and urea derivatives of benzothiazole as Raf-1 inhibitor.
    Song EY; Kaur N; Park MY; Jin Y; Lee K; Kim G; Lee KY; Yang JS; Shin JH; Nam KY; No KT; Han G
    Eur J Med Chem; 2008 Jul; 43(7):1519-24. PubMed ID: 18023932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of aminoquinazoline derivatives and their antiproliferative activities against melanoma cell line.
    Lee J; Nam BS; Kim H; Oh CH; Lee SH; Cho SJ; Sim TB; Hah JM; Kim DJ; Tae J; Yoo KH
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5722-5. PubMed ID: 20797858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and cell growth inhibitory activity of a series of novel aminosubstituted xantheno[1,2-d]imidazoles in breast cancer cells.
    Kostakis IK; Pouli N; Marakos P; Kousidou OCh; Roussidis A; Tzanakakis GN; Karamanos NK
    Bioorg Med Chem; 2008 Mar; 16(6):3445-55. PubMed ID: 18296053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
    Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
    Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
    Gollob JA; Wilhelm S; Carter C; Kelley SL
    Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tri- and tetrasubstituted imidazoles as p38α mitogen-activated protein kinase inhibitors.
    Laufer S; Hauser D; Stegmiller T; Bracht C; Ruff K; Schattel V; Albrecht W; Koch P
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6671-5. PubMed ID: 20934337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
    Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors.
    Buchstaller HP; Burgdorf L; Finsinger D; Stieber F; Sirrenberg C; Amendt C; Grell M; Zenke F; Krier M
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2264-9. PubMed ID: 21420298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.